Test methods for efficacy assessment of antimicrobial coatings are not modelled on a hospital environment, and instead use high humidity (>90%) high temperature (37 °C), and no airflow. Therefore, an inoculum will not dry, resulting in an antimicrobial surface exhibiting prolonged antimicrobial activity, as moisture is critical to activity. Liquids will dry quicker in a hospital ward, resulting in a reduced antimicrobial efficacy compared to
STSM: Fabrication of electrospun antimicrobial nanofibers based on phytochemicals
STSM asignment description: The objective of this STSM is the fabrication of phytochemical based antimicrobial nanofibers via electrospinning which may find application in medical devices for the purpose of infection prevention and control. Through collaboration with TÜBİTAK MRC and Zurich University, it is planned to perform the nanofabrication studies and some of the preliminary morphological characterisations at the Zurich University, and then to done the
STSM: Evaluating the anti-biofilm activity of surfaces composed of ZnO/Ag heterostructures
STSM completed: ZnO/Ag heterostructures are expected to exhibit UVA-induced photocatalytic effect which are due to the presence of ZnO and magnified by the presence of Ag nanoparticles. While these surfaces have been shown to be effective against planktonic bacteria, their action against biofilms is still unknown. As such, the objective of this STSM is to assess the efficacy of ZnO/Ag surfaces against mono- or multi-species
Antimicrobial Peptides and their Potential to Combat Antimicrobial Resistance Opinion on the Use Of Antimicrobial Coatings In Health-Care Settings
Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Maria Olivia Pereira, Assistant Professor University of Minho Department of Biological Engineering Braga, Portugal, Professor in Biomedical Engineering Principal Investigator in the Biofilm Group. This presentation can be also viewed in SlideShare
AMR in Grece: View from the Veterinary Sector
Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Dr. Theofilos Papadopoulos, DVM, MSc, MPH, PhD, Aristotle’s University of Thessaloniki, Veterinary Research Institute of Thessaloniki This presentation can be also viewed in SlideShare.
Novel Antimicrobial Strategies to Combat Biomaterial‐Associated Infections Opinion on the use of AMCs in health‐care setting
Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Martijn Riool, Postdoc at University of Amsterdam, AMC ‐ CRANIOSAFE (NL STW) Note: this presentation can be also viewed in SlideShare
Emergence and spread of antibiotic resistance
Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Tanel Tenson, Professor in the technology of antimicrobial compounds University of Tartu, Estonia. Note: this presentation can be also viewed in SlideShare
Trends on Health-Care Associated Infections and Infection Control in Estonia and in Europe
Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Pille Märtin, Infection control doctor West-Tallinn Central Hospital, Chief specialist Dep. Of Communicable Diseases surveillance and control Health Board of Estonia Note: this presentation can be also viewed in SlideShare
AMR: view from the hospital’s laboratory. Usage of AMCs in health‐care settings
Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Siiri Kõljalg MD, PhD University of Tartu, Tartu University Hospital Note: this presentation can be also viewed in SlideShare
Use of antibiotics in health care and problems with AMR in Estonia: comparison with Europe
Presentation given during Cost AMiCI meeting in Tallinn Nov 2017 by Irja Lutsar MD, PhD Professor of Medical Microbiology University of Tartu